Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 423
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07340541 | Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies | ||
| NCT05096923 | UNC Childhood, Adolescent, and Young Adult Cancer Cohort | ||
| NCT01000883 | Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior | ||
| NCT06276946 | Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia | ||
| NCT03569605 | Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback Strategies | ||
| NCT04136912 | 3-D Super Resolution Ultrasound Microvascular Imaging | ||
| NCT04092257 | HPV-Based Screen-and-Treat Demonstration Project in Lilongwe | ||
| NCT02191982 | The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older | ||
| NCT01204450 | Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma | ||
| NCT05978570 | Physical Therapy in Pre-cystectomy Patients | ||
| NCT03594162 | Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch | ||
| NCT04176497 | PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study | ||
| NCT07599462 | Pilot Study of Communication for Dual Users of Cigarettes and E-cigarettes | ||
| NCT06989489 | Implementation of an Oral Chemotherapy Adherence Intervention | ||
| NCT01488357 | Patient Preferences for Breast Reconstruction After Mastectomy | ||
| NCT04548648 | A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas | ||
| NCT04243941 | PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer | ||
| NCT06411756 | Physical Activity Centers Empowerment | ||
| NCT07605949 | Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML | ||
| NCT00610948 | Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment | ||
| NCT04073966 | MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets | ||
| NCT06902311 | Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST) | ||
| NCT05911321 | Isa-Pom-Dex in Elderly/Frail Subjects With RRMM | ||
| NCT03361800 | Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC | ||
| NCT03977233 | Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | ||
| NCT02306252 | The CARE Program: CAncer REhabilitation Pilot Study for Older Adults | ||
| NCT02008058 | Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer | ||
| NCT04753086 | Patient Related Outcomes for Gynecologic Radiation Oncology | ||
| NCT07025785 | Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer | ||
| NCT03769415 | Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA | ||
| NCT01263418 | Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas | ||
| NCT06483555 | Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel | ||
| NCT00088985 | Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer | ||
| NCT06902376 | XL092 and Cemiplimab in BRAF WT Thyroid Cancer | ||
| NCT04134325 | Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma | ||
| NCT00257426 | Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer | ||
| NCT04083495 | CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma | ||
| NCT04033419 | Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer | ||
| NCT01560663 | Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer | ||
| NCT02786628 | Assessing Physical Fitness in Cancer Patients With Cardiopulmonary Exercise Testing and Wearable Data Generation | ||
| NCT05542407 | ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer | ||
| NCT06075316 | Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS) | ||
| NCT07292818 | Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies | ||
| NCT00005827 | Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer | ||
| NCT03951090 | Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients | ||
| NCT04342260 | Improving Quality of Life After Thoracic Surgery Using Patient-Reported Outcomes | ||
| NCT01688323 | Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer | ||
| NCT01665703 | Imaging Correlates of Renal Cell Carcinoma Biological Features | ||
| NCT03176082 | Mailed Reminders Plus Fecal Immunochemical Testing | ||
| NCT02276560 | Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC |
